Lack of B Cell Dysfunction Is Associated with Functional, gp120-Dominant Antibody Responses in Breast Milk of Simian Immunodeficiency Virus-Infected African Green Monkeys

ABSTRACT The design of an effective vaccine to reduce the incidence of mother-to-child transmission (MTCT) of human immunodeficiency virus (HIV) via breastfeeding will require identification of protective immune responses that block postnatal virus acquisition. Natural hosts of simian immunodeficiency virus (SIV) sustain nonpathogenic infection and rarely transmit the virus to their infants despite high milk virus RNA loads. This is in contrast to HIV-infected women and SIV-infected rhesus macaques (RhMs), nonnatural hosts which exhibit higher rates of postnatal virus transmission. In this study, we compared the systemic and mucosal B cell responses of lactating, SIV-infected African green monkeys (AGMs), a natural host species, to that of SIV-infected RhMs and HIV-infected women. AGMs did not demonstrate hypergammaglobulinemia or accumulate circulating memory B cells during chronic SIV infection. Moreover, the milk of SIV-infected AGMs contained higher proportions of naive B cells than RhMs. Interestingly, AGMs exhibited robust milk and plasma Env binding antibody responses that were one to two logs higher than those in RhMs and humans and demonstrated autologous neutralizing responses in milk at 1 year postinfection. Furthermore, the plasma and milk Env gp120-binding antibody responses were equivalent to or predominant over Env gp140-binding antibody responses in AGMs, in contrast to that in RhMs and humans. The strong gp120-specific, functional antibody responses in the milk of SIV-infected AGMs may contribute to the rarity of postnatal transmission observed in natural SIV hosts.

[1]  W. Blattner,et al.  HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life , 2013, Mucosal Immunology.

[2]  J. Overbaugh,et al.  HIV-Specific Antibodies Capable of ADCC Are Common in Breastmilk and Are Associated with Reduced Risk of Transmission in Women with High Viral Loads , 2012, PLoS pathogens.

[3]  L. Carbone Pain management standards in the eighth edition of the Guide for the Care and Use of Laboratory Animals. , 2012, Journal of the American Association for Laboratory Animal Science : JAALAS.

[4]  G. Shaw,et al.  Mucosal Simian Immunodeficiency Virus Transmission in African Green Monkeys: Susceptibility to Infection Is Proportional to Target Cell Availability at Mucosal Sites , 2012, Journal of Virology.

[5]  T. Kepler,et al.  Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated , 2011, The Journal of experimental medicine.

[6]  Y. Richard,et al.  Marginal Zone B-Cells, a Gatekeeper of Innate Immunity , 2011, Front. Immun..

[7]  A. Lackner,et al.  Simian immunodeficiency virus infection in rhesus macaques induces selective tissue specific B cell defects in double positive CD21+CD27+ memory B cells. , 2011, Clinical immunology.

[8]  M. Seaman,et al.  High Cell-Free Virus Load and Robust Autologous Humoral Immune Responses in Breast Milk of Simian Immunodeficiency Virus-Infected African Green Monkeys , 2011, Journal of Virology.

[9]  B. Haynes,et al.  HIV-Specific Functional Antibody Responses in Breast Milk Mirror Those in Plasma and Are Primarily Mediated by IgG Antibodies , 2011, Journal of Virology.

[10]  G. Silvestri,et al.  Mother-to-Infant Transmission of Simian Immunodeficiency Virus Is Rare in Sooty Mangabeys and Is Associated with Low Viremia , 2011, Journal of Virology.

[11]  C. L. Yau,et al.  Double-Positive CD21+CD27+ B Cells Are Highly Proliferating Memory Cells and Their Distribution Differs in Mucosal and Peripheral Tissues , 2011, PloS one.

[12]  G. Freeman,et al.  Acute depletion of activated memory B cells involves the PD-1 pathway in rapidly progressing SIV-infected macaques. , 2010, The Journal of clinical investigation.

[13]  G. Learn,et al.  Genetic Identity and Biological Phenotype of a Transmitted/Founder Virus Representative of Nonpathogenic Simian Immunodeficiency Virus Infection in African Green Monkeys , 2010, Journal of Virology.

[14]  B. Hahn,et al.  A Novel CCR5 Mutation Common in Sooty Mangabeys Reveals SIVsmm Infection of CCR5-Null Natural Hosts and Efficient Alternative Coreceptor Use In Vivo , 2010, PLoS pathogens.

[15]  M. Hughes,et al.  Antiretroviral regimens in pregnancy and breast-feeding in Botswana. , 2010, The New England journal of medicine.

[16]  Michael G Hudgens,et al.  Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. , 2010, The New England journal of medicine.

[17]  N. Letvin,et al.  Limited Contribution of Mucosal IgA to Simian Immunodeficiency Virus (SIV)-Specific Neutralizing Antibody Response and Virus Envelope Evolution in Breast Milk of SIV-Infected, Lactating Rhesus Monkeys , 2010, Journal of Virology.

[18]  L. Picker,et al.  Evidence of Early B-Cell Dysregulation in Simian Immunodeficiency Virus Infection: Rapid Depletion of Naïve and Memory B-Cell Subsets with Delayed Reconstitution of the Naïve B-Cell Population , 2009, Journal of Virology.

[19]  Holly Janes,et al.  Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies , 2009, Journal of Virology.

[20]  G. Aldrovandi,et al.  High concentrations of interleukin 15 in breast milk are associated with protection against postnatal HIV transmission. , 2009, The Journal of infectious diseases.

[21]  D. Douek,et al.  Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts , 2009, Nature Medicine.

[22]  Jörn E. Schmitz,et al.  Polyclonal B Cell Differentiation and Loss of Gastrointestinal Tract Germinal Centers in the Earliest Stages of HIV-1 Infection , 2009, PLoS medicine.

[23]  Y. Richard,et al.  Tissue-Specific B-Cell Dysfunction and Generalized Memory B-Cell Loss during Acute SIV Infection , 2009, PloS one.

[24]  Susan Moir,et al.  B cells in HIV infection and disease , 2009, Nature Reviews Immunology.

[25]  Vicki C. Ashley,et al.  Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia , 2008, Journal of Virology.

[26]  R. Gelman,et al.  Potent Simian Immunodeficiency Virus-Specific Cellular Immune Responses in the Breast Milk of Simian Immunodeficiency Virus-Infected, Lactating Rhesus Monkeys1 , 2008, The Journal of Immunology.

[27]  Guido Silvestri,et al.  Into the wild: simian immunodeficiency virus (SIV) infection in natural hosts. , 2008, Trends in immunology.

[28]  Wei Wang,et al.  Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals , 2008, The Journal of experimental medicine.

[29]  L. Mofenson,et al.  Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. , 2008, The New England journal of medicine.

[30]  Susan Moir,et al.  Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease. , 2008, The Journal of allergy and clinical immunology.

[31]  P. Roques,et al.  Paucity of CD4+ CCR5+ T Cells May Prevent Transmission of Simian Immunodeficiency Virus in Natural Nonhuman Primate Hosts by Breast-Feeding , 2008, Journal of Virology.

[32]  A. Perelson,et al.  Simian Immunodeficiency Virus SIVagm Dynamics in African Green Monkeys , 2008, Journal of Virology.

[33]  Guido Silvestri,et al.  Understanding the benign nature of SIV infection in natural hosts. , 2007, The Journal of clinical investigation.

[34]  S. Munir Alam,et al.  Human Immunodeficiency Virus Type 1 gp41 Antibodies That Mask Membrane Proximal Region Epitopes: Antibody Binding Kinetics, Induction, and Potential for Regulation in Acute Infection , 2007, Journal of Virology.

[35]  H. Katinger,et al.  Time dependence of protective post-exposure prophylaxis with human monoclonal antibodies against pathogenic SHIV challenge in newborn macaques. , 2007, Virology.

[36]  Ronald S Veazey,et al.  Paucity of CD4 (cid:1) CCR5 (cid:1) T cells is a typical feature of natural SIV hosts , 2022 .

[37]  S. Staprans,et al.  Correlates of Preserved CD4+ T Cell Homeostasis during Natural, Nonpathogenic Simian Immunodeficiency Virus Infection of Sooty Mangabeys: Implications for AIDS Pathogenesis , 2007, The Journal of Immunology.

[38]  M. Clerici,et al.  Hiv-specific secretory IgA in breast milk of HIV-positive mothers is not associated with protection against HIV transmission among breast-fed infants. , 2006, The Journal of pediatrics.

[39]  Feng Gao,et al.  A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses. , 2006, Virology.

[40]  L. Lopalco,et al.  Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. , 2006, Blood.

[41]  Peter B Gilbert,et al.  Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. , 2006, JAMA.

[42]  C. Apetrei,et al.  Simian immunodeficiency viruses replication dynamics in African non‐human primate hosts: common patterns and species‐specific differences , 2006, Journal of medical primatology.

[43]  S. Staprans,et al.  Perturbations of Cell Cycle Control in T Cells Contribute to the Different Outcomes of Simian Immunodeficiency Virus Infection in Rhesus Macaques and Sooty Mangabeys , 2006, Journal of Virology.

[44]  L. Lopalco,et al.  Primary HIV-1 Infection Sets the Stage for Important B Lymphocyte Dysfunctions , 2005, Retrovirology.

[45]  Xiping Wei,et al.  Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies , 2005, Journal of Virology.

[46]  Renate Kunert,et al.  Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies , 2005, Science.

[47]  J. Rychert,et al.  The Antibody Response to SIV in Lactating Rhesus Macaques , 2005, Journal of acquired immune deficiency syndromes.

[48]  F. Chiodi,et al.  Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. , 2004, Blood.

[49]  J. Read Human milk, breastfeeding, and transmission of human immunodeficiency virus type 1 in the United States. American Academy of Pediatrics Committee on Pediatric AIDS. , 2003, Pediatrics.

[50]  A. Amedee,et al.  Mother‐to‐infant transmission of SIV via breast‐feeding in rhesus macaques , 2003, Journal of medical primatology.

[51]  H. McClure,et al.  Antibody protection: passive immunization of neonates against oral AIDS virus challenge. , 2003, Vaccine.

[52]  R. Koup,et al.  Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. , 2003, Immunity.

[53]  B. Berkhout,et al.  Characterization of the anti-HIV effects of native lactoferrin and other milk proteins and protein-derived peptides. , 2002, Antiviral research.

[54]  Hermann Katinger,et al.  Passive immunization against oral AIDS virus transmission: An approach to prevent mother‐to‐infant HIV‐1 transmission? , 2001, Journal of medical primatology.

[55]  A. Komiyama,et al.  Mechanism of hypergammaglobulinemia by HIV infection: circulating memory B-cell reduction with plasmacytosis. , 2001, Clinical immunology.

[56]  F. Chiodi,et al.  Loss of memory (CD27) B lymphocytes in HIV-1 infection , 2001, AIDS.

[57]  B. Richardson,et al.  Timing of breast milk HIV-1 transmission: a meta-analysis. , 2001, East African medical journal.

[58]  Francis A. Plummer,et al.  Risk factors for postnatal mother–child transmission of HIV-1 , 2000, AIDS.

[59]  R. Lynch,et al.  Modified wick method using Weck-Cel sponges for collection of human rectal secretions and analysis of mucosal HIV antibody. , 2000, Journal of acquired immune deficiency syndromes.

[60]  F. Onyango,et al.  Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. , 2000, JAMA.

[61]  M. Kazatchkine,et al.  Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV. , 2000, The Journal of infectious diseases.

[62]  D. Montefiori,et al.  Neutralizing Antibodies in Sera from Macaques Immunized with Attenuated Simian Immunodeficiency Virus , 1998, Journal of Virology.

[63]  R. Means,et al.  Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus , 1997, Journal of virology.

[64]  S. Wahl,et al.  Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. , 1997, Blood.

[65]  L. Mofenson,et al.  Evaluation and medical treatment of the HIV-exposed infant. American Academy of Pediatrics. Committee on Pediatric AIDS. , 1997, Pediatrics.

[66]  A. Gettie,et al.  Apparent lack of vertical transmission of simian immunodeficiency virus (SIV) in naturally infected African green monkeys, Cercopithecus aethiops. , 1995, Annals of tropical medicine and parasitology.

[67]  K. Holmes,et al.  Human immunodeficiency virus type 1 IgA antibody in breast milk and serum. , 1994, The Pediatric infectious disease journal.

[68]  P. Fultz,et al.  Prevalence of natural infection with simian immunodeficiency virus and simian T-cell leukemia virus type I in a breeding colony of sooty mangabey monkeys. , 1990, AIDS.